問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
劉峰誠
下載
2025-06-01 - 2029-04-30
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2023-06-16 - 2026-07-31
moderate-to-severe systemic lupus erythematosus (SLE)
tablet
Participate Sites11Sites
Not yet recruiting1Sites
Recruiting10Sites
2021-10-01 - 2028-07-07
Participate Sites8Sites
Recruiting8Sites
2021-06-01 - 2026-06-30
Participate Sites10Sites
Not yet recruiting3Sites
Recruiting7Sites
2024-09-01 - 2026-12-31
Participate Sites2Sites
Recruiting2Sites
2018-08-01 - 2025-12-31
2024-03-01 - 2027-05-31
Participate Sites4Sites
Recruiting4Sites
2024-10-04 - 2027-03-31
2022-12-01 - 2025-12-31
xxxxxx
amlitelimab
全部
